Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NAMPT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SPRR1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADGRD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELK4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFAP126 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNIP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ETV6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RETNLB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLA2G4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01527 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NUB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF213 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR4271 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM56 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
QKI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on